• About us
• Contact

Advertisement

Product › Details

cancer drug

	Next higher product group	pharmaceutical
	Status	1998-01-01 sales existent

Record changed: 2025-03-23

Advertisement

More documents for cancer drug

• [1] Oxford BioTherapeutics Ltd.. (3/19/25). "Press Release: Oxford BioTherapeutics Enters into a Strategic Collaboration with Roche to Discover Novel Targets for Antibody-Based Therapeutics for the Treatment of Cancer". Oxford & San Jose, CA....
• [2] Araris Biotech AG. (3/17/25). "Press Release: Taiho Pharmaceutical to Acquire Next-Generation ADC Drug Discovery Company Araris Biotech"....
• [3] AstraZeneca plc. (3/17/25). "Press Release: AstraZeneca Enters License Agreement with Alteogen for Subcutaneous Formulations of Multiple Oncology Assets"....
• [4] Valo Therapeutics Oy. (3/10/25). "Press Release: Valo Therapeutics Announces EUR 19m of Investment Funding and Expanded Clinical Trials". Helsinki, Naples & Perth....
• [5] T-Therapeutics Ltd.. (3/10/25). "Press Release: T-Therapeutics Appoints Theodora Harold as Chief Executive Officer, Reflecting Company’s Ambitious Growth Plans and Progression into Therapeutic Development". Cambridge....
• [6] Jazz Pharmaceuticals plc. (3/5/25). "Press Release: Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio". Dublin & Durham, NC....
• [7] Callio Therapeutics. (3/3/25). "Press Release: Callio Therapeutics Launches with US$187 Million Series A to Advance Multi-Payload Antibody-Drug Conjugate Platform Through Clinical Proof-of-Concept". Seattle, WA & Singapore....
• [8] FibroGen, Inc.. (2/20/25). "Press Release: FibroGen Announces the Sale of FibroGen China to AstraZeneca for Approximately $160 Million". San Francisco, CA....
• [9] Ona Therapeutics. (2/19/25). "Press Release: Ona Therapeutics Strengthens Leadership Team to Accelerate First-in-Class ADCs into Clinical Development Across Cancer Types"....
• [10] Tubulis GmbH. (2/6/25). "Press Release: Tubulis Strengthens Executive Leadership with Appointment of Matthew Norkunas as Chief Financial Officer and President of Tubulis Inc.". Munich....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.